Roxanne Lagano - Apr 18, 2023 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role
Executive Vice President
Signature
/s/ Lauren Luptak, as Attorney-in-Fact
Stock symbol
ZTS
Transactions as of
Apr 18, 2023
Transactions value $
-$416,830
Form type
4
Date filed
4/19/2023, 04:18 PM
Previous filing
Apr 10, 2023
Next filing
Jul 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZTS Common Stock Options Exercise $171K +2.33K +8.83% $73.24 28.7K Apr 18, 2023 Direct F1
transaction ZTS Common Stock Options Exercise $176K +2.01K +7.01% $87.51 30.7K Apr 18, 2023 Direct F1
transaction ZTS Common Stock Sale -$763K -4.34K -14.13% $175.94 26.4K Apr 18, 2023 Direct F2
holding ZTS Common Stock 793 Apr 18, 2023 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Stock Option Options Exercise $0 -2.33K -9.48% $0.00 22.2K Apr 18, 2023 Common Stock 2.33K Direct F4, F5, F6, F7, F8
transaction ZTS Stock Option Options Exercise $0 -2.01K -9.04% $0.00 20.2K Apr 18, 2023 Common Stock 2.01K Direct F4, F6, F7, F9, F10
holding ZTS Stock Option 6.54K Apr 18, 2023 Common Stock 6.54K $162.07 Direct F7, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
F2 The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
F3 Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of March 31, 2023.
F4 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F5 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option.
F6 Each option vests on the third anniversary of the date of grant.
F7 Each option expires on the tenth anniversary of the date of grant.
F8 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
F9 2,010 options granted on February 12, 2019 at an exercise price of $87.51 per option.
F10 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
F11 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
F12 One-third of each option will vest on the first, second and third anniversaries of the date of grant.